Literature DB >> 3203420

Antitumor activity exhibited by orally administered extract from fruit body of Grifola frondosa (maitake).

I Hishida, H Nanba, H Kuroda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3203420     DOI： 10.1248/cpb.36.1819

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  9 in total

1.  The medicinal value of the mushroomGrifola.

Authors:  S C Jong; J M Birmingham
Journal:  World J Microbiol Biotechnol       Date:  1990-09       Impact factor: 3.312

2.  Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production.

Authors:  Hong Lin; Sandy W Y Cheung; Mirjana Nesin; Barrie R Cassileth; Susanna Cunningham-Rundles
Journal:  Clin Vaccine Immunol       Date:  2006-11-08

3.  Possible disease remission in patient with invasive bladder cancer with D-fraction regimen.

Authors:  Srinivas Rajamahanty; Brandon Louie; Cormac O'Neill; Muhammad Choudhury; Sensuke Konno
Journal:  Int J Gen Med       Date:  2009-07-30

Review 4.  Immunomodulatory dietary polysaccharides: a systematic review of the literature.

Authors:  Jane E Ramberg; Erika D Nelson; Robert A Sinnott
Journal:  Nutr J       Date:  2010-11-18       Impact factor: 3.271

5.  Medicinal mushrooms: Towards a new horizon.

Authors:  A Ganeshpurkar; G Rai; A P Jain
Journal:  Pharmacogn Rev       Date:  2010-07

6.  Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice.

Authors:  Agustina Roldan-Deamicis; Eliana Alonso; Belén Brie; Diego Aguilera Braico; Gabriela Andrea Balogh
Journal:  Cancer Med       Date:  2016-07-11       Impact factor: 4.452

7.  Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells.

Authors:  Eliana Noelia Alonso; María Julia Ferronato; María Eugenia Fermento; Norberto Ariel Gandini; Alejandro López Romero; Josefina Alejandra Guevara; María Marta Facchinetti; Alejandro Carlos Curino
Journal:  Oncotarget       Date:  2018-05-04

Review 8.  SX-fraction: Promise for novel treatment of type 2 diabetes.

Authors:  Sensuke Konno
Journal:  World J Diabetes       Date:  2020-12-15

Review 9.  The translational aspect of complementary and alternative medicine for cancer with particular emphasis on Kampo.

Authors:  Marie Amitani; Haruka Amitani; Robert A Sloan; Hajime Suzuki; Nanami Sameshima; Akihiro Asakawa; Yasuhito Nerome; Tetsuhiro Owaki; Akio Inui; Etsuo Hoshino
Journal:  Front Pharmacol       Date:  2015-08-06       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.